{"disease":{"id":"symptomatic-neurogenic-orthostatic-hypertension","name":"symptomatic neurogenic orthostatic hypertension"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04688632","title":"Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Theravance Biopharma","has_results":false},{"nct_id":"NCT04200573","title":"Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Theravance Biopharma","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}